News

A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School at The University of Texas Health Science Center at Houston...

People with the degenerative disorder Huntington's disease could receive pioneering treatment with stem cells to try to slow development of symptoms. Cardiff University plans to begin the first transplants at a specialist brain centre by the end of the year. A new...

Thalassemia is a genetic blood disease, common across the wider Middle East and South Asia, in which victims are not able to make enough hemoglobin - a necessary component in healthy red blood cells, carrying oxygen to all parts of the body – and, thus, suffer from...

Cerebral palsy (CP) is a physical disability that affects movement and posture. It is a permanent life-long condition, where the brain injury is stable, but co-occurring orthopedic conditions can worsen over time. It is due to damage to the developing brain either...

A Sydney toddler whose umbilical cord blood was stored to help treat her sister's Type 1 diabetes has had it reinfused after showing signs of the disease herself. Earlier this year Lucy Hinchion, aged 20 months, became the youngest child in the world to receive her...

The War on Parkinson's: Stem Cells Successfully Injected into Patient's Brain A team of Australian researchers have successfully performed a procedure injecting stem cells into the brain of a Parkinson's Disease patient. The researchers are hopeful that this could be...

Doctors in Seattle call it a very big deal: a study out this week that shows increased benefits of umbilical cord blood transplants among patients with leukemia. The study, led by researchers at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance...

Scientists have discovered a new way to replicate the regenerative power of stem cells in the lab, which could lead to powerful treatments for injuries and diseases. In a new paper published in the journal ACS Nano, Dr. Catherine Berry and Professor Matthew Dalby from...

Scientists grow tiny pea-sized 'human lungs' in the laboratory giving hope to thousands of patients with fatal conditions Tiny 'human lungs' have been grown in a laboratory which could revolutionise understanding of fatal diseases. The breakthrough was made using...

Phase 3 Clinical Trial using haematopoietic stem cells to treat patients with beta-thalassemia opens. Bluebird Bio, a Cambridge, Massachusetts-based biotech, last week opened its enrolment of a Phase 3 trial of its LentiGlobin gene therapy. BlueBird's Lentiglobin gene...